Thalassaemia
AT Taher, DJ Weatherall, MD Cappellini - The Lancet, 2018 - thelancet.com
Inherited haemoglobin disorders, including thalassaemia and sickle-cell disease, are the
most common monogenic diseases worldwide. Several clinical forms of α-thalassaemia and …
most common monogenic diseases worldwide. Several clinical forms of α-thalassaemia and …
Iron chelators in treatment of iron overload
Patients suffering from iron overload can experience serious complications. In such patients,
various organs, such as endocrine glands and liver, can be damaged. Although iron is a …
various organs, such as endocrine glands and liver, can be damaged. Although iron is a …
[HTML][HTML] Challenges of blood transfusions in β-thalassemia
FT Shah, F Sayani, S Trompeter, E Drasar, A Piga - Blood reviews, 2019 - Elsevier
Patients with β-thalassemia major (BTM) require regular blood transfusions, supported by
appropriate iron chelation therapy (ICT), throughout their life. β-thalassemia is a global …
appropriate iron chelation therapy (ICT), throughout their life. β-thalassemia is a global …
β-Thalassemias
AT Taher, KM Musallam… - New England Journal of …, 2021 - Mass Medical Soc
β-Thalassemias Defective synthesis of the β-globin chain causes recessively inherited
disorders characterized by inadequate hemoglobin production and chronic anemia …
disorders characterized by inadequate hemoglobin production and chronic anemia …
[PDF][PDF] Inherited haemoglobin disorders: an increasing global health problem
DJ Weatherall, JB Clegg - Bulletin of the World Health …, 2001 - SciELO Public Health
Pese a los grandes avances de nuestros conocimientos sobre la patología molecular, la
fisiopatología y el control y manejo de las hemoglobinopatías hereditarias, miles de …
fisiopatología y el control y manejo de las hemoglobinopatías hereditarias, miles de …
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
LJ Anderson, S Holden, B Davis, E Prescott… - European heart …, 2001 - academic.oup.com
Aims To develop and validate a non-invasive method for measuring myocardial iron in order
to allow diagnosis and treatment before overt cardiomyopathy and failure develops …
to allow diagnosis and treatment before overt cardiomyopathy and failure develops …
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine
C Borgna-Pignatti, S Rugolotto, P De Stefano… - …, 2004 - haematologica.org
BACKGROUND AND OBJECTIVES: Seven Italian centers reported data on survival, causes
of death and appearance of complications in patients with thalassemia major. The …
of death and appearance of complications in patients with thalassemia major. The …
Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association
This aim of this statement is to report an expert consensus on the diagnosis and treatment of
cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover …
cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover …
Iron-chelating therapy and the treatment of thalassemia
NF Olivieri, GM Brittenham - … Journal of the American Society of …, 1997 - ashpublications.org
(BM) expansion, permit normal development throughout childhood, and extend survival. 1 In
parallel, transfusions re- Early studies of the use of neocytes, or young RBCs, sult in a …
parallel, transfusions re- Early studies of the use of neocytes, or young RBCs, sult in a …